Skip to main content

Weight Gain After Breast Cancer Development Tied to Heart Failure Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 10, 2025.

By Elana Gotkine HealthDay Reporter

FRIDAY, Jan. 10, 2025 -- For women with newly diagnosed invasive breast cancer (BC), weight gain is associated with an increased risk for heart failure, according to a research letter published online Jan. 9 in JAMA Oncology.

Wonyoung Jung, M.D., Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues examined the association between weight changes and heart failure risk after BC development using the National Health Insurance Service database of the Republic of Korea. The cohort included 43,717 women newly diagnosed with invasive BC without prior heart failure before or within one year of diagnosis. Weight change was assessed from screenings before (zero to two years) and after (0.5 to 2.5 years) BC diagnosis and was classified based on percentage changes.

The researchers found that 6.1, 15.7, 63.9, 10.7, and 3.5 percent of patients had more than 10 percent weight loss, had 5 to 10 percent weight loss, maintained weight, had 5 to 10 percent weight gain, and had more than 10 percent weight gain, respectively. After adjusting for cardiovascular risk factors, cancer treatment, and sociodemographic factors, 5 to 10 percent weight gain was associated with an increased risk for heart failure (adjusted hazard ratio, 1.59) and more than 10 percent weight gain was associated with further increased risk (adjusted hazard ratio, 1.85) compared with weight maintainers during a mean follow-up of 4.67 years. There was no association seen for weight loss with heart failure risk.

"The findings underscore the importance of effective weight intervention in the oncological care of patients with BC, particularly within the first few years after diagnosis, to protect cardiovascular health," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

Exercise, Rehab Services Can Be Integrated Into Breast Cancer Care

MONDAY, April 28, 2025 -- Exercise and rehabilitation services for patients with breast cancer through a clinical workflow algorithm called CORE (Comprehensive Oncology...

Low-to-Moderate Agreement Seen for Diagnosing Breast Cancer-Related Lymphedema

THURSDAY, April 24, 2025 -- Different measurement tools and diagnostic criteria show low-to-moderate agreement for diagnosing breast cancer-related lymphedema (BCRL), according to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.